Michael David Katz M.D., Director at Hanover Bancorp, Inc. /NY (HNVR), bought 65 shares at $20.11 ($1K) on 2022-08-12, disclosed to the SEC on 2022-08-15.
Open-market purchase of $1k HNVR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.99 | 25 | $500 | 38.3% |
| 2 | $20.11 | 40 | $804 | 61.7% |
| Total | $20.06 avg | 65 | $1K | 100% |
| Filing → |
| HNVR | BUY | 2022-05-11 | $105K | — | Filing → |